Prospective Observational Cohort Study to Describe the Use of Vectibix in Combination With Chemotherapy in Routine Clinical Practice for Patients With Wild-type RAS Metastatic Colorectal Cancer

Trial Profile

Prospective Observational Cohort Study to Describe the Use of Vectibix in Combination With Chemotherapy in Routine Clinical Practice for Patients With Wild-type RAS Metastatic Colorectal Cancer

Completed
Phase of Trial: Phase IV

Latest Information Update: 13 Dec 2016

At a glance

  • Drugs Panitumumab (Primary) ; Antineoplastics
  • Indications Colorectal cancer
  • Focus Therapeutic Use
  • Sponsors Amgen
  • Most Recent Events

    • 07 Dec 2016 Status changed from active, no longer recruiting to completed.
    • 26 Feb 2016 Planned End Date changed from 1 Jan 2017 to 1 Nov 2016 as per ClinicalTrials.gov record.
    • 04 Dec 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top